CTRI/2023/11/059698尚未招募2 期
“A clinical study to determine the efficacy of Amritadya Guggulu and Haritaki Churna in the management of Medoroga w.s.r to Dyslipidemia .â€
Prof Anjana Mishra1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年11月20日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- A clinical study to determine the efficacy of Amritadya Guggulu & Haritaki Churna in the management of medoroga w.s.r to Dyslipidemia
研究概览
简要总结
I plan to publish my work after completing the research trial as soon as possible. A minimum number of 30 patients will be selected from OPD and IPD of Kayachikitsa Department in Rajiv Gandhi Govt Post Graduate Ayurvedic College and hospital Paprola Distt Kangra. A total number of 30 patients will be divided into 2 groups containing 15 patients each. One group will be managed with tab atorvastatin 10 mg once a day. The other group will be managed with haritaki churna for koshtha shudhi followed by Amritadya guggulu 500 mg Twice daily for a period of 8 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Open Label
入排标准
- 年龄范围
- 40.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients who present with signs and symptoms of medoroga Patients having serum cholesterol 200 to 300mg/dl, s.
- •Triglycerides 150 to 350 mg/dl, S.
- •LDL 100 to 200 mg/dl, S.
- •VLDL 30 TO 100 mg/dl and S.
- •HDL 20 to 40 mg/dl.
排除标准
- •Patients having past history of Myocardial infarction, unstable angina, congestive cardiac failure and cerebro vascular accident.
- •Patients having past illness like carcinoma, renal and liver disorders Pregnant females and lactating mother.
结局指标
主要结局
A clinical study to determine the efficacy of Amritadya Guggulu & Haritaki Churna in the management of medoroga w.s.r to Dyslipidemia
时间窗: 8 weeks
次要结局
- To assess the clinical safety & untoward effects of Amritadya Guggulu & Haritaki Churna in patients of Medoroga w.s.r Dyslipidemia(8 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
To study the efficacy ofAshwagandhadi Avaleha as an Adjuvant with Anti Tubercular Treatment.CTRI/2021/05/033863Principal60
尚未招募
不适用
Efficacy of Sanjeevani Vati in Infective DiarrhoeaCTRI/2021/08/035634Principal RGGPG Ayurvedic College and Hospital Paprola20
已完成
不适用
TRACE ll Prospective study: Outcome in patients undergoing postponed elective surgery during the COVID-19 pandemicNL-OMON24690MUMC+2,500
已完成
不适用
The efficacy of Daikenchuto(TJ-100) on abdominal pain and abdominal fullness feeling in the patients with fecal incontinence.Abdominal pain and abdominal fullness feeling in the patients with fecal incontinenceJPRN-jRCTs061180031Shimazutsu Kazufumi21
尚未招募
不适用
Prevention of fallingFallingFunctional decline ElderlyPreventionNL-OMON26703one496